Robert N. McBurney
Vorsitzender bei Differential Proteomics, Inc.
Profil
Robert N.
McBurney was the founder of Optimal Medicine Ltd.
(founded in 2009) and held the title of Non-Executive Director.
He is currently the Chairman at Differential Proteomics, Inc., a Trustee at Franklin W.
Olin College of Engineering, and the Chief Research Officer at Accelerated Cure Project for Multiple Sclerosis (since 2019).
Previously, he served as the Director at The Medical Research Council, President at CeNeS Pharmaceuticals, Inc. and CeNeS Pharmaceuticals Plc, Chief Scientific Officer at BG Medicine, Inc., Member at the University of Cambridge, Principal at Newcastle University, and Executive Vice President at TheraGenetics Ltd.
Dr. McBurney completed his undergraduate and doctorate degrees at The University of New South Wales.
Aktive Positionen von Robert N. McBurney
| Unternehmen | Position | Beginn |
|---|---|---|
Accelerated Cure Project for Multiple Sclerosis
 Accelerated Cure Project for Multiple Sclerosis Miscellaneous Commercial ServicesCommercial Services The Accelerated Cure Project for Multiple Sclerosis cures multiple sclerosis (MS) by determining the cause. It specializes in research, biobanking, collaboration, fundraising, nonprofit. The company was founded by Art Mellor in 2000 and is headquartered in Waltham, MA. | Technik-/Wissenschafts-/F&E-Leiter | 05.12.2019 |
| Franklin W. Olin College of Engineering | Direktor/Vorstandsmitglied | - |
| Differential Proteomics, Inc. | Vorsitzender | - |
Ehemalige bekannte Positionen von Robert N. McBurney
| Unternehmen | Position | Ende |
|---|---|---|
Optimal Medicine Ltd.
 Optimal Medicine Ltd. Packaged SoftwareTechnology Services Optimal Medicine Ltd. offers individualized clinical decision support software for mental health disorders. The firm’s products include ADHD care, behavioral health, and rheumatoid arthritis. Its products employ clinical and genetic information about an individual patient to generate information that guides physicians on the treatment for that patient. The company was founded by Janet Munro and Robert McBurney in 2009 and is headquartered in Newcastle-upon-Tyne, the United Kingdom. | Gründer | - |
| University of Cambridge | Corporate Officer/Principal | - |
TheraGenetics Ltd.
 TheraGenetics Ltd. Pharmaceuticals: MajorHealth Technology Theragenetics Ltd. operates as a personalized medicine diagnostics company that develops and commercializes portfolio of pharmacogenetic diagnostic tests. The company was founded on March 13, 2006 and is headquartered in Wetherby, the United Kingdom. | Corporate Officer/Principal | - |
| Newcastle University | Corporate Officer/Principal | - |
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ausbildung von Robert N. McBurney
| The University of New South Wales | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BG MEDICINE, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
CeNeS Pharmaceuticals, Inc.
 CeNeS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CeNeS Pharmaceuticals, Inc. discovers and develops proprietary pharmaceuticals to prevent and treat disorders and injuries of the nervous system. The company is headquartered in Cambridge, MA. | Health Technology |
CeNeS Pharmaceuticals Plc
 CeNeS Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology CeNeS Pharmaceuticals Plc engages in the discovery and development of drugs. The company was founded by Alan Gilbert Goodman in 1997 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
The Medical Research Council
The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Commercial Services |
TheraGenetics Ltd.
TheraGenetics Ltd. Pharmaceuticals: MajorHealth Technology Theragenetics Ltd. operates as a personalized medicine diagnostics company that develops and commercializes portfolio of pharmacogenetic diagnostic tests. The company was founded on March 13, 2006 and is headquartered in Wetherby, the United Kingdom. | Health Technology |
| Differential Proteomics, Inc. | |
Accelerated Cure Project for Multiple Sclerosis
Accelerated Cure Project for Multiple Sclerosis Miscellaneous Commercial ServicesCommercial Services The Accelerated Cure Project for Multiple Sclerosis cures multiple sclerosis (MS) by determining the cause. It specializes in research, biobanking, collaboration, fundraising, nonprofit. The company was founded by Art Mellor in 2000 and is headquartered in Waltham, MA. | Commercial Services |
Optimal Medicine Ltd.
Optimal Medicine Ltd. Packaged SoftwareTechnology Services Optimal Medicine Ltd. offers individualized clinical decision support software for mental health disorders. The firm’s products include ADHD care, behavioral health, and rheumatoid arthritis. Its products employ clinical and genetic information about an individual patient to generate information that guides physicians on the treatment for that patient. The company was founded by Janet Munro and Robert McBurney in 2009 and is headquartered in Newcastle-upon-Tyne, the United Kingdom. | Technology Services |
